Home/Pipeline/Second Approved Therapy

Second Approved Therapy

Respiratory/Rare Disease

ApprovedCommercial

Key Facts

Indication
Respiratory/Rare Disease
Phase
Approved
Status
Commercial
Company

About Insmed

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform lives of patients facing serious diseases. The company has achieved commercial success with approved therapies in the US and EU, while advancing multiple programs through clinical development. Insmed has been consistently recognized as Science magazine's #1 Top Biopharma Employer for five consecutive years and maintains a culture of collaboration and innovation across 9 corporate offices worldwide.

View full company profile